FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to methods for neurostimulation therapy of disorders. The method involves the direct or indirect brain stimulation which is specified from the group: insula, subcallosal area, cingulate cortex, thalamus, prefrontal cortex, brain stem, cerebellum, and white matter tracts. What is also used is the brain stimulation combined with the cranial nerve stimulation. A stimulation mode is programmed to optimise physically the stimulation signal parameters to improve at least one of the symptoms such as, e.g. bulimia, or other eating disorder.
EFFECT: method extends the range of products for treating eating disorders.
30 cl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PANCREATIC DISORDERS BY NERVE STIMULATION APPARATUS | 2006 |
|
RU2491104C2 |
| METHOD FOR NEUROELECTROSTIMULATION AND DEVICE THEREFOR | 2014 |
|
RU2580972C2 |
| METHOD FOR ASSESSING SEVERITY OF INFANTILE CEREBRAL PARALYSIS (ICP) AND PSYCHO-SPEECH DELAY (PSD) | 2014 |
|
RU2561290C1 |
| METHOD FOR INCREASING THE LEVEL OF CONSCIOUSNESS OF PATIENTS WITH LONG-TERM IMPAIRMENT OF CONSCIOUSNESS | 2022 |
|
RU2783006C1 |
| METHOD FOR ELECTROMAGNETIC STIMULATION OF CENTRAL AND PERIPHERAL NERVE SYSTEM | 2012 |
|
RU2499614C1 |
| DEVICE FOR NEUROELECTROSTIMULATION | 2016 |
|
RU2653681C2 |
| IMPLANTED TO PATIENT DEVICE (VERSIONS) | 2008 |
|
RU2488374C2 |
| TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF NEURONS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 1999 |
|
RU2155063C1 |
| METHOD FOR TREATING PARALYSES AND PARESES | 2005 |
|
RU2284198C1 |
| METHOD OF TREATING NEURALGIA AND NEURITIS OF TRIGEMINAL NERVE | 2014 |
|
RU2551228C1 |
